
According to data from Benzinga Pro, during Q1, CytoSorbents's (NASDAQ:CTSO) reported sales totaled $8.69 million. Despite a 3.66% increase in earnings, the company posted a loss of $8.97 million. In Q4, CytoSorbents brought in $10.78 million in sales but lost $9.31 million in earnings.